biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by frohlir944on Oct 01, 2018 5:13pm

128 Views

Post# 28724881

RE:RE:RE:RE:RE:RE:RE:Daily Dump

Problem, NO, the smart ones among us buyers are currently winning the lottery by being able to buy these shares ( trying to bring the price down is only rewarding the strongest among us and will have the reverse affect after reality sets in. We won’t let these shares go cheaply, meaning its the price will be driven up even more by The Who now holds these shares.

Thank You!

Bullboard Posts

Canadian government to fund Electric Royalties portfolio property